Orkla (ORK) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
12 Feb, 2026Executive summary
Organic growth for Q4 2025 was 4.5% year-over-year, with underlying adjusted EBIT for consolidated portfolio companies up 17% and adjusted EPS of NOK 1.74, reflecting strong operational performance and margin improvement.
Jotun delivered 28% underlying operating profit growth, and Orkla Snacks achieved 16% EBIT adjusted growth in Q4, with all major portfolio companies except Foods contributing positively.
The Board proposes a total dividend of NOK 6 per share for 2025, including an extra NOK 2.2, and a NOK 4 billion share buyback program is ongoing.
Strategic progress included the IPO of Orkla India, sale of Hydro Power assets, and further portfolio simplification.
Full-year 2025 saw organic growth of 3.5%, underlying EBIT (adj.) growth of 7%, and cash conversion of 101%.
Financial highlights
Q4 2025 operating revenues were NOK 18,775 million, up 2% year-over-year; adjusted EBIT was NOK 1,977 million, up 12%.
Adjusted EPS reached NOK 1.74, up 24% year-over-year; profit before tax rose 24% to NOK 2,140 million.
Cash flow from operations was NOK 7.8 billion for 2025, with cash flow before capital allocation at NOK 6.9 billion.
Net debt stood at NOK 14.2 billion, equal to 1.4x EBITDA (0.9x excluding Orkla Food Ingredients).
Profit from associates and JVs was NOK 505 million, up 36% year-over-year, mainly from Jotun.
Outlook and guidance
Jotun expects sales growth to outpace the market in 2026, but margin pressure from competition and negative currency effects is anticipated.
Portfolio companies are targeting 8–10% CAGR in underlying adjusted EBIT and 1.5–2.0 pp margin improvement through 2026.
Orkla Snacks anticipates favorable input cost development in 2026, while Orkla Health expects continued negative impact from cod liver oil price trends.
Inflation in key input costs (meat, marine, berries, cocoa) is expected to persist into 2026.
Portfolio companies are developing strategy plans for 2027–2030, focusing on volume growth and cost efficiency.
Latest events from Orkla
- Aims for 12-14% annual TSR with stable dividends and a NOK 4B share buyback in 2025-26.ORK
Investor presentation11 Mar 2026 - Strong EBIT and EPS growth, margin gains, and strategic moves highlight robust performance.ORK
Q2 20243 Feb 2026 - Q3 delivered 10% EPS and 17% EBIT growth, strong cash flow, and broad segment gains.ORK
Q3 202418 Jan 2026 - Strong global growth, robust financials, and sustainability leadership position for future expansion.ORK
Investor lunch presentation16 Jan 2026 - Targeting 12-14% annual TSR with a focus on organic growth and portfolio optimization.ORK
UBS Global Consumer and Retail Conference presentation16 Jan 2026 - Strong TSR, streamlined portfolio, and operational focus drive progress toward 2026 targets.ORK
Capital Markets Update 202516 Jan 2026 - Targets 12-14% annual TSR with NOK 70.7bn revenue and a diversified consumer-focused portfolio.ORK
SEB Nordic Seminar presentation16 Jan 2026 - Strong growth, margin expansion, and asset sales drive a proposed NOK 10 dividend.ORK
Q4 20248 Jan 2026 - Q1 2025 delivered 7.6% EBIT growth, 19% higher EPS, and strong margin improvements.ORK
Q1 202517 Nov 2025